Endoscopic ultrasound-guided fine needle core biopsy (EUS-FNB) has been used as an effective method of diagnosing pancreatic malignant lesions. It has the advantage of providing well preserved tissue for histologic grading and subsequent molecular biological analysis.

Market Analysis and Insights: Global EUS-Guided Fine Needle Biopsy Market
The global EUS-Guided Fine Needle Biopsy market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global EUS-Guided Fine Needle Biopsy Scope and Market Size
The global EUS-Guided Fine Needle Biopsy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global EUS-Guided Fine Needle Biopsy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Enteral Endoscopic Ultrasound Needles
Bronchial Endoscopic Ultrasound Needles

Segment by Application
Hospitals
Clinics
Others

The EUS-Guided Fine Needle Biopsy market is analysed and market size information is provided by regions (countries). Segment by Application, the EUS-Guided Fine Needle Biopsy market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Olympus
Medtronic
Cook Medical
Boston Scientific